Veeva Systems (VEEV)
(Delayed Data from NYSE)
$214.88 USD
+0.49 (0.23%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $212.21 -2.67 (-1.24%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$214.88 USD
+0.49 (0.23%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $212.21 -2.67 (-1.24%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Zacks News
Masimo's (MASI) New Offering to Serve Personalized Audio Market
by Zacks Equity Research
Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
by Zacks Equity Research
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs
by Zacks Equity Research
Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.
BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
by Zacks Equity Research
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Applied Materials (AMAT) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Applied Materials (AMAT) delivered earnings and revenue surprises of 6.09% and 2.04%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
Merit Medical (MMSI) to Expand Product Suite Via New Launch
by Zacks Equity Research
Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.
Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
by Zacks Equity Research
Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.
Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
by Zacks Equity Research
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Why the Market Dipped But Veeva Systems (VEEV) Gained Today
by Zacks Equity Research
In the most recent trading session, Veeva Systems (VEEV) closed at $203.86, indicating a +0.04% shift from the previous trading day.
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
by Zacks Equity Research
Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
by Zacks Equity Research
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
D-Wave Quantum Inc. (QBTS) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
D-WAVE QUANTUM (QBTS) delivered earnings and revenue surprises of -37.50% and 10.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day.
Bull of the Day: Veeva Systems (VEEV)
by Benjamin Rains
The tech firm and the stock are proven winners. Now might be the time for investors to heed tried-and-true investment advice and buy Veeva while others are fearful.
Diodes (DIOD) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Diodes (DIOD) delivered earnings and revenue surprises of 3.70% and 0.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
8x8 (EGHT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
8x8 (EGHT) delivered earnings and revenue surprises of 14.29% and 0.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.
Veeva Systems (VEEV) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Veeva Systems (VEEV) concluded the recent trading session at $203.14, signifying a -0.15% move from its prior day's close.
The Zacks Analyst Blog Highlights Pinterest, Veeva Systems, Twilio, Toast and Snap
by Zacks Equity Research
Pinterest, Veeva Systems, Twilio, Toast and Snap are included in this Analyst Blog.
Invest in 5 Internet Software Stocks to Enhance Your Portfolio
by Nalak Das
We have narrowed our search to five Internet software stocks with strong potential for 2024. these are: PINS, TOST, VEEV, SNAP, TWLO.
Why Veeva Systems (VEEV) Outpaced the Stock Market Today
by Zacks Equity Research
Veeva Systems (VEEV) reachead $201.58 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close.
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
by Zacks Equity Research
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.